Aflac Incorporated (AFL) Balance Sheet
As of 2026-06-30 (10-Q), Aflac Incorporated (AFL) reported total assets of $116.0B, total liabilities of $85.6B and shareholders' equity of $30.3B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $6.1B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AFLAflac IncorporatedFollow AFL — free
—
Price chart with a free account
- Market cap
- 60.4B
- P/E TTM
- 13.0
- Dividend yield
- 2.0%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.32 | 2.12 | 2.25 | 2.04 | 2.54 | 4.66 | 4.35 | 4.86 | 3.49 | 4.34 | 4.90 | 5.14 | 5.05 | 3.94 | 4.31 | 6.23 | 6.25 | 6.12 | |
| Total assets | 84.11 | 100.24 | 116.24 | 121.31 | 121.31 | 119.73 | 118.26 | 129.82 | 137.22 | 140.41 | 152.77 | 165.09 | 157.54 | 131.74 | 126.72 | 117.57 | 116.47 | 115.96 | |
| Total liabilities | 75.69 | 89.98 | 103.29 | 115.12 | 106.69 | 101.42 | 100.55 | 109.34 | 112.62 | 116.94 | 123.81 | 131.53 | 124.29 | 111.60 | 104.74 | 91.47 | 86.98 | 85.65 | |
| Shareholders' equity | 8.42 | 10.54 | 12.95 | 15.98 | 14.62 | 18.35 | 17.71 | 20.48 | 24.60 | 23.46 | 28.96 | 33.56 | 17.03 | 20.14 | 21.99 | 26.10 | 29.49 | 30.31 |
USD billions · SEC XBRL
Aflac Incorporated — questions
- How much cash does Aflac Incorporated have?
- $6.1B in cash and cash equivalents as of 2026-06-30.
- What are Aflac Incorporated's total assets?
- $116.0B as of 2026-06-30.
- What is Aflac Incorporated's shareholders' equity?
- $30.3B as of 2026-06-30.
Every figure on this page comes from Aflac Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.